Pharmaceutical care for antithrombotic therapy in dialysis patients with acute kidney injury combined with VTE and HIT after PCI

VernacularTitle:PCI术后急性肾损伤合并VTE和HIT的透析患者抗栓治疗的药学监护
Author: Xiu-Mei LIU ¹ ; Li-Ping DU
Author Information

1. 河南中医药大学第五临床医学院、郑州人民医院药学部,河南郑州 450003
Keywords: percutaneous coronary intervention; acute kidney injury; heparin-induced thrombocytopenia; venous thromboembolism; pharmaceutical care
From: The Chinese Journal of Clinical Pharmacology 2024;40(8):1222-1225
CountryChina
Language:Chinese
Abstract: Clinical pharmacists participated in the treatment of patients with acute kidney injury complicated with venous thromboembolism(VTE)and heparin-induced thrombocytopenia(HIT)after percutaneous coronary intervention(PCI),consulted the guidelines and literature timely and provided individualized antithrombotic therapy according to the characteristics of the patient's condition.When combined with VTE,apixaban was used in addition to aspirin and clopidogrel for antithrombotic therapy,and no serious adverse events such as bleeding or thromboembolism occurred.When suspected HIT,heparin were discontinued in time,and platelet count returned to normal.Pharmaceutical care was given to patients during antithrombotic therapy to ensure the safety of patients'medication.